Department of Clinical and Experimental Sciences, Surgical Clinic, University of Brescia, ASST Spedali Civili, Brescia, Italy.
Centro per la Diagnosi e Cura delle Neoplasie Endocrine e delle Malattie della Tiroide, University of Brescia, Brescia, Italy.
Langenbecks Arch Surg. 2024 Nov 18;409(1):350. doi: 10.1007/s00423-024-03539-x.
Evaluate the changes in quality of life (QoL) in patients affected by tertiary hyperparathyroidism (THPT) after surgical treatment using the Parathyroidectomy Assessment of Symptoms (PAS) and Short Form-36 (SF-36) questionnaires.
Single centre longitudinal retrospective, single-institution analysis of 34 patients with THPT and submitted to parathyroidectomy between 2015 and 2021. The PAS and SF-36 questionnaires were administered before surgery and 24 months after discharge.
A significative QoL amelioration was registered in physical SF-36 (42.4 ± 11.7 vs 56.7 ± 9.2; P < 0.001), mental SF-36 (47.3 ± 12.1 vs 61.8 ± 7.9; P < 0.001) and PAS score (582 ± 163 vs 293 ± 141; P < 0.001) with a significative improvement of all the 13 symptoms considered. We found that pre-operative intact parathormone (iPTH) levels, preoperative T-score and time of haemodialysis before RTX were predictors of both PAS and SF-36 mental score modifications. A positive correlation was also fund between pre-operative PAS values and their post operative cutback.
Parathyroidectomy for THPT brings to a concrete amelioration of all the disease-related and nonspecific symptoms with significative improvement of QoL. To develop a tailored approach of every patient's needs, from diagnosis to future treatment, we suggest to introduce the symptoms assessment scale as standard stage in periodic evaluations.
使用甲状旁腺切除术症状评估 (PAS) 和健康调查简表 36 项 (SF-36) 问卷评估接受甲状旁腺切除术治疗的三发性甲状旁腺功能亢进症 (THPT) 患者的生活质量 (QoL) 变化。
对 2015 年至 2021 年间接受甲状旁腺切除术的 34 例 THPT 患者进行单中心回顾性、单机构分析。在手术前和出院后 24 个月进行 PAS 和 SF-36 问卷评估。
SF-36 躯体健康评分(42.4±11.7 对 56.7±9.2;P<0.001)、SF-36 心理健康评分(47.3±12.1 对 61.8±7.9;P<0.001)和 PAS 评分(582±163 对 293±141;P<0.001)均有显著改善,考虑的 13 种症状均有显著改善。我们发现,术前全段甲状旁腺素 (iPTH) 水平、术前 T 评分和 RTX 前血液透析时间是 PAS 和 SF-36 心理健康评分变化的预测因素。还发现术前 PAS 值与术后下降之间存在正相关。
甲状旁腺切除术治疗 THPT 可显著改善与疾病相关的所有症状和非特异性症状,显著提高生活质量。为了制定每位患者从诊断到未来治疗的个体化需求方法,我们建议将症状评估量表作为定期评估的标准纳入。